PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 80 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $114,625,000 | -38.7% | 5,827,415 | 0.0% | 8.82% | -41.0% |
| Q3 2021 | $187,060,000 | -5.2% | 5,827,415 | 0.0% | 14.97% | -17.7% |
| Q2 2021 | $197,258,000 | -9.9% | 5,827,415 | 0.0% | 18.19% | +3.6% |
| Q1 2021 | $218,878,000 | +13.1% | 5,827,415 | 0.0% | 17.56% | +17.8% |
| Q4 2020 | $193,587,000 | -9.4% | 5,827,415 | 0.0% | 14.91% | -22.3% |
| Q3 2020 | $213,691,000 | +11.4% | 5,827,415 | 0.0% | 19.18% | +13.9% |
| Q2 2020 | $191,780,000 | +2.0% | 5,827,415 | -20.0% | 16.84% | -21.0% |
| Q1 2020 | $188,080,000 | -17.1% | 7,284,269 | 0.0% | 21.32% | -43.9% |
| Q4 2019 | $226,832,000 | – | 7,284,269 | – | 38.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |